lymphnode cancer Morbus Hodgkin
Conditions
Interventions
None listed
Sponsors
Stichting Kinderoncologie Nederland
Eligibility
Age
2 Years to 17 Years
Inclusion criteria
Inclusion criteria: Pediatric patients treated in the Netherlands according to the COG Hodgkin Disease protocols, boys > 8 years, girls > 9 years
Exclusion criteria
Exclusion criteria: Pediatric patients not treated on a COG Hodgkins'Disease protocol, boys
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This study will give insight inthe direct and late effects of the used chemotherapy in pediatrics patients with HL using the most novel fertility markers. If these chemotherapeutic agents do not show gonadal damage, it will support future studies with these agents. If certain regimens indicate direct or late gonadal toxicity, this will urge early counceling in this cohort. | — |
Countries
Netherlands
Outcome results
None listed